Riluzole is a glutamate-modulating agent with neuroprotective properties approved for use in amyotrophic lateral sclerosis. The efficacy and safety of riluzole vs placebo as an adjunct to ...
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
Vol. 10, No. 3, Abstracts: 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL) (May, 2001), p. 281 (1 page) Quality of Life Research is an international, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback